UBS lowered the firm’s price target on Eastman Chemical (EMN) to $101 from $107 and keeps a Buy rating on the shares. Better than feared tariff impacts could support downstream firms in the quarter, while commodities are likely to remain under pressure with weaker demand trends, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN:
- Eastman Chemical Appoints Damon Audia to Board
- Eastman Chemical: Buy Rating Affirmed Amid Strategic Flexibility and Positive Segment Momentum
- Eastman Chemical’s Strategic Adjustments Signal Growth Potential Despite Setbacks
- Morgan Stanley believes Eastman likely to still move forward with Longview plant
- Energy Department cancels $375M Eastman award, Bloomberg says